FolioLanternBeta
IONSIonis Pharmaceuticals Inc

Holly Kordasiewicz

EVP, Chief Development Officer at Ionis Pharmaceuticals Inc, as of Jul 9, 2026Sold $4.8M of stock in the past 12 months: 93% under a disclosed plan and 7% to cover taxes.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
65K
shares sold, past 12 months
3
days with sales
$4.5M
largest single day, Jun 12, 2026
1
company filed for

Share of stake sold and shares held at Ionis Pharmaceuticals Inc are not shown: the holdings do not reconcile with the filings. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
OctNovDecJan 2026: $313K to cover taxesJanFebMarAprMayJun 2026: $4.5M under a disclosed plan$4.5MJunJul 2026: $31K under a disclosed planJulAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Ionis Pharmaceuticals Inc (IONS)EVP, Chief Development OfficerJan 6, 2026Jul 9, 2026

Recent filings

The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.